短效β-2激动剂的非处方使用:系统性审查
Zhe Chi Loh1, Rabia Hussain2, Siew Chin Ong1
1School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Gelugor, Pulau Pinang, Malaysia.
Journal of pharmaceutical policy and practice
|October 9, 2023
概括
非处方购买和过度使用短效β-2激动剂 (SABA) 是常见的,导致失控的喘. 改善对SABA风险的患者教育和适当的喘管理对于预防不良结果至关重要.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 短效β-2激动剂 (SABA) 广泛用于缓解喘.
- 过度使用SABA与喘恶化和死亡率的增加有关.
- 非处方药 (OTC) 的可用性有助于SABA的过度使用和治疗不足的喘.
研究的目的:
- 系统地审查OTCSABA购买和过度使用的流行情况.
- 识别购买或过度使用OTC SABA的个人特征.
- 确定导致OTC SABA购买或过度使用的因素.
主要方法:
- 对2000年至2023年4月期间发表的原始研究文章进行系统审查.
- 搜索的数据库:PubMed,Scopus,Springer Link,Google Scholar,CINAHL,APA PsycArticles. 搜索的数据库:PubMed,Scopus,Springer Link,Google Scholar,CINAHL,APA PsycArticles. 搜索的数据库:PubMed,Scopus,Springer Link,Google Scholar,CINAHL,APA PsycArticles. 搜索的数据库:PubMed,Scopus,APA PsycArticles. 搜索的数据库:PubMed,Scopus,Springer Link,Google Scholar,CINAHL,APA PsycArticles. 搜索的数据库:PubMed,APA PsycArticles. 搜索的数据库:PubMed,APA PsycArticles. 搜索的数据库:PubMed,APA PsycArticles.
- 包括报告OTCSABA使用的流行率,特征和因素的研究;不包括评论,评论和临床试验.
主要成果:
- 场外SABA用户的流行率从1.4%到39.6%不等.
- 在OTC用户中,SABA过度使用者在14%至66.4%之间.
- 与过度使用相关的因素包括中度至重度的喘,不经常使用控制药物,以及对SABA风险缺乏认识.
结论:
- 场外SABA购买和过度使用是严重的公共卫生问题.
- 不良后果包括失控的喘和增加医疗保健利用率.
- 加强患者对喘管理和SABA长期影响的教育至关重要.
相关概念视频
Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...


